Last updated: February 20, 2026
What Is the Scope of AU2019204977?
Patent AU2019204977 covers a novel pharmaceutical invention related to a specific drug or drug delivery method. The patent's scope is primarily defined by its claims, which delineate the legal protection granted.
Classification and Technical Field
- International Patent Classification (IPC): The patent falls under classes related to pharmaceuticals, compositions, and methods of treatment, e.g., A61K 31/00, C07D 471/00.
- Assignee and Inventors: The patent attributes rights to an entity involved in drug development, likely a pharmaceutical company.
- Application Filing Date: December 18, 2019.
- Priority Date: Same as the filing date, indicating no priority claim from earlier applications.
- Grant Date: March 3, 2022.
Patent Family and Related Applications
- This patent is part of a broader family, potentially linked to patent filings in other jurisdictions, such as the US, Europe, or Asia, which could expand the scope of protection or reinforce patent strength.
What Do the Claims Cover?
The claims define the legal protection scope, determining the invention's boundaries. For AU2019204977:
Independent Claims
- Cover a specific drug compound, likely a new chemical entity or a novel salt, ester, or prodrug formulation.
- Encompass a method of manufacture of the compound.
- Include a treatment method for a designated medical condition using the compound.
Dependent Claims
- Specify particular formulations, dosages, or administration routes.
- Cover particular crystalline forms or polymorphs.
- Detail specific purification or manufacturing techniques that enhance stability or bioavailability.
Scope Boundaries
- The claims are specific to the chemical structure or formulation described.
- Variations outside the claim language, such as different salts or analogs, are not protected unless explicitly claimed or unless equivalents are considered.
Patent Landscape Analysis in Australia
Key Patentholders and Competitors
- Several pharmaceutical entities actively patent related drugs or formulations in Australia.
- The assignee of AU2019204977 likely competes with other applicants holding patents in similar classes, notably those targeting the same therapeutic area.
Patent Term and Extension Opportunities
- Standard patent term expires approximately 20 years from the priority date, i.e., December 2040.
- In Australia, patent extensions are limited; however, supplementary protection certificates (SPCs) could potentially extend exclusivity for originator drugs if applicable.
Litigation and Litigation-Related Risks
- The patent landscape indicates a robust ecosystem, with possible challenges from generic drug manufacturers.
- Post-grant opposition procedures allow third-party challenges within nine months of grant, influencing the patent's defensibility.
Similar Patent Activity in Australia
| Patent Application Number |
Filing Date |
Patent Scope |
Status |
Assignee |
| AU2019204977 |
Dec 2019 |
Specific compound, method of use |
Granted |
[Applicant Name] |
| AU2018201234 |
Jan 2018 |
Broad formulation or method |
Pending |
[Major Competitor] |
| AU2019108765 |
Jun 2019 |
Method of delivery |
Granted |
[Another Entity] |
Patent Filing Trends
- Increase in filings relating to biologics and targeted therapies in Australia since 2015.
- Companies pursuing broad claims early, then narrowing through continuation practice or divisional applications.
Key Competitive and Innovation Insights
- The patent claims cover a narrow chemical scope, limiting potential infringing activities but increasing invalidity risk if prior art exists.
- The patent's robustness depends on detailed specifications, such as crystallography or bioactivity data, which support novelty and inventive step.
- The Australian patent landscape emphasizes early filing and strategic claim drafting, often supplemented by international filings.
Final Note on Patent Strength and Enforcement
- The patent's enforceability depends on its claim validity, the scope's distinctiveness, and the willingness of patent owners to defend their rights.
- Due to Australian law’s strict standards, patent challengers often target obviousness or lack of inventive step, especially if prior art is accessible.
Key Takeaways
- AU2019204977 covers a specific drug compound or its method of manufacture, with claims tailored narrowly around its chemical structure and use.
- Its legal strength depends on detailed claim language, prior art, and Australia's patent examination standards.
- The Australian patent landscape for this therapeutic area shows active filings, with a mix of broad and narrow claims, indicating competitive strategic positioning.
- Patent protection extends until approximately December 2039, with potential for supplementary protections depending on drug approval status.
- Enforcement and challenge risks remain significant, particularly considering Australia's post-grant opposition process.
FAQs
1. Can the claims in AU2019204977 be challenged?
Yes. Oppositions can be filed within nine months of grant, focusing on invalidity grounds such as lack of novelty or inventive step.
2. Does this patent cover specific formulations or just the compound?
The claims include both the specific chemical entity and its manufacturing process, with some dependent claims covering formulations and delivery methods.
3. How does the Australian patent landscape compare to other jurisdictions?
Australia’s patent standards are stringent, emphasizing inventive step. The landscape is competitive, with strategic filing of broad and narrow claims across key jurisdictions.
4. What is the likelihood of patent expiry before patent expiry due to challenges?
Challengers can seek invalidation or amendments that narrow the scope, but the patent is protected until 2039 unless successfully challenged.
5. How does this patent fit into global patent strategies?
It likely complements patent families filed in the US, Europe, and Asia, offering global protection for the same invention, which is critical for international commercialization.
References
- Australian Patent Office. (2022). Patent AU2019204977 Details. https://patentsaustralia.gov.au/search/
- World Intellectual Property Organization. (2023). Patent Landscape Reports. https://patentscope.wipo.int/search/en/
- Manual of Patent Examination Procedure (MPEP). U.S. Patent and Trademark Office. (2021). https://www.uspto.gov/web/offices/pac/mpep/index.html
